ArticleInternational journal of molecular sciences2024

Effect of Empagliflozin with or without the Addition of Evolocumab on HDL Subspecies in Individuals with Type 2 Diabetes Mellitus: A Post Hoc Analysis of the EXCEED-BHS3 Trial.

Isabella Bonilha et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.